NMR STRUCTURAL STUDIES OF CBFA RUNT DOMAIN DNA COMPLEX
NMR STRUCTURAL STUDIES OF CBFA RUNT DOMAIN DNA COMPLEX
批准号:
6170709
负责人:
JOHN Hackett BUSHWELLER
金额:
$13.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 2001-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core binding factor (CBF) was originally identified as a DNA-binding
protein that specifically binds to the asymmetric sequence PyGPyGGT,
corresponding to the highly conserved "core" site in mammalian type C
retrovirus enhancers. CBF binding sites have subsequently been
identified in a number of T cell specific genes, providing evidence for
the role of CBF as a T-cell transcription factor. Additional evidence
for the importance of CBF has come from knockouts of both genes in mice
which were shown to be embryonic lethal and which also were shown to
have blockage in hematopoietic development. Isolation and subsequent
cloning of CBF showed the protein to be a heteromer consisting of an
alpha subunit and a beta subunit. The alpha subunit contacts the DNA
directly, whereas the beta subunit does not, as indicated by the lack
of any changes in the number of phosphate contacts made by alpha in the
presence of beta. Binding of the beta subunit to the alpha subunit
increases the affinity of the alpha subunit for DNA sixfold without
altering the sequence specificity. The alpha subunit contains a 128
amino acid region displaying a high homology to the Drosophila
segmentation protein called Runt. This domain is referred to as the
Runt domain and has been shown to be responsible for the both the DNA
and beta-binding capabilities of the alpha subunit.
Two of the four genes encoding CBF subunits are proto-oncogenes commonly
activated in human leukemias. The inversion and translocations
identified in these genes are associated with 30 percent of de novo
acute myeloid leukemias in humans. The importance of CBF in leukemia
as well as in its normal role as a transcription factor makes
elucidation of its function at the molecular level extremely interesting
and potentially therapeutically useful. In addition, the lack of any
resemblance of either subunit to any known structural motifs makes them
important targets for structure determination.
The overall objective of our work is the thorough biophysical and
structural characterization of the functional domains of the two
subunits of CBF as well as the relevant complexes involved. We are
employing NMR spectroscopy for the structure determinations of
CBFbeta(1-141) as well as a Runt domain-DNA complex. The aims of this
proposal are to determine the structure of the Runt domain-DNA complex
and map the CBFbeta binding site on the Runt domain.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis
-
批准号:10378336
-
项目类别:
-
资助金额:$6.78万
-
财政年份:2019
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis
-
批准号:10434785
-
项目类别:
-
资助金额:$58.98万
-
财政年份:2019
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Small Molecule Inhibitors of a Reader of DNA Methylation
-
批准号:9808362
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2019
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis
-
批准号:10667450
-
项目类别:
-
资助金额:$58.98万
-
财政年份:2019
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis
-
批准号:10198868
-
项目类别:
-
资助金额:$60.18万
-
财政年份:2019
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis
-
批准号:10524126
-
项目类别:
-
资助金额:$6.58万
-
财政年份:2019
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis
-
批准号:10738333
-
项目类别:
-
资助金额:$6.58万
-
财政年份:2019
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Targeted Small Molecule Inhibitors for Inv(16) Leukemia
-
批准号:10307548
-
项目类别:
-
资助金额:$66.72万
-
财政年份:2018
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Targeted Small Molecule Inhibitors for Inv(16) Leukemia
-
批准号:10520054
-
项目类别:
-
资助金额:$66.69万
-
财政年份:2018
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Targeted Small Molecule Inhibitors for Inv(16) Leukemia
-
批准号:10056213
-
项目类别:
-
资助金额:$67.89万
-
财政年份:2018
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Structure/Function of AF9 and MLL-AF9
-
批准号:8974717
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2014
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Structure/Function of AF9 and MLL-AF9
-
批准号:8311653
-
项目类别:
-
资助金额:$46.68万
-
财政年份:2011
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Structure/Function of AF9 and MLL-AF9
-
批准号:8504799
-
项目类别:
-
资助金额:$43.88万
-
财政年份:2011
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Structure/Function of AF9 and MLL-AF9
-
批准号:8193766
-
项目类别:
-
资助金额:$49.71万
-
财政年份:2011
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Structure/Function of AF9 and MLL-AF9
-
批准号:8677790
-
项目类别:
-
资助金额:$45.28万
-
财政年份:2011
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC
-
批准号:8071203
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2010
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC
-
批准号:8457974
-
项目类别:
-
资助金额:$59.31万
-
财政年份:2010
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC
-
批准号:7892198
-
项目类别:
-
资助金额:$68.69万
-
财政年份:2010
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Solution NMR Structure and Function of the Integral Membrane Protein DsbB
-
批准号:7811029
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2010
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC
-
批准号:8242873
-
项目类别:
-
资助金额:$63.09万
-
财政年份:2010
-
负责人:JOHN Hackett BUSHWELLER
-
依托单位:
海外基金